About
ProSciento’s state-of-the-art clinical research unit (CRU) specializes in metabolic studies and is located in Chula Vista, CA. Since 2003, the CRU has conducted more than 300 clinical research studies in NASH, diabetes, obesity, and related metabolic diseases for small and large molecule therapies, biologics, biosimilars, and medical devices. Research conducted at the CRU has been at the forefront of metabolic clinical research, contributing to the development of advanced methodologies, including imaging and circulating biomarkers, glucose clamp procedures, tracer studies, and glucose monitoring systems.